Garcia-Donas et al. 16 found that VEGFR rs307826 and rs307821 as well as CYP3A5 rs776746 were significantly correlated with the PFS of RCC sufferers treated with sunitinib in a European population. Here, CYP3A5 is linked to renal cell adenocarcinoma.